Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116770813 | 11677081 | 3 | F | 20151008 | 20160711 | 20151028 | 20160722 | EXP | IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-070604 | BRISTOL MYERS SQUIBB | 83.78 | YR | M | Y | 0.00000 | 20160722 | CN | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116770813 | 11677081 | 1 | PS | COUMADIN | WARFARIN SODIUM | 1 | Oral | 1 UNIT, PRN | U | U | 9218 | 1 | DF | TABLET | |||||
| 116770813 | 11677081 | 2 | C | FINASTERIDE. | FINASTERIDE | 1 | Oral | 1 UNIT, UNK | 0 | 1 | DF | ||||||||
| 116770813 | 11677081 | 3 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 10 MG, UNK | 0 | 10 | MG | ||||||||
| 116770813 | 11677081 | 4 | C | CHOLECALCIFEROL | CHOLECALCIFEROL | 1 | Oral | 1 DF, UNK | 0 | 1 | DF | ||||||||
| 116770813 | 11677081 | 5 | C | CARDICOR | BISOPROLOL | 1 | Oral | 1 UNIT, UNK | 0 | 1 | DF | ||||||||
| 116770813 | 11677081 | 6 | C | PRINZIDE | HYDROCHLOROTHIAZIDELISINOPRIL | 1 | Oral | 1 DF, UNK | 0 | 1 | DF | ||||||||
| 116770813 | 11677081 | 7 | C | PRADIF | TAMSULOSIN HYDROCHLORIDE | 1 | Oral | 0.4 MG, UNK | 0 | .4 | MG | CAPSULE | |||||||
| 116770813 | 11677081 | 8 | C | ANTACAL | AMLODIPINE BESYLATE | 1 | Oral | 0.5 UNIT, UNK | 0 | .5 | DF | TABLET | |||||||
| 116770813 | 11677081 | 9 | C | DIFOSFONAL | CLODRONATE DISODIUM | 1 | Unknown | 1 UNIT, UNK | 0 | 1 | DF |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116770813 | 11677081 | 1 | Atrial fibrillation |
| 116770813 | 11677081 | 2 | Product used for unknown indication |
| 116770813 | 11677081 | 3 | Product used for unknown indication |
| 116770813 | 11677081 | 4 | Product used for unknown indication |
| 116770813 | 11677081 | 5 | Product used for unknown indication |
| 116770813 | 11677081 | 6 | Product used for unknown indication |
| 116770813 | 11677081 | 7 | Product used for unknown indication |
| 116770813 | 11677081 | 8 | Product used for unknown indication |
| 116770813 | 11677081 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116770813 | 11677081 | HO |
| 116770813 | 11677081 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116770813 | 11677081 | Duodenal ulcer | |
| 116770813 | 11677081 | Melaena | |
| 116770813 | 11677081 | Off label use | |
| 116770813 | 11677081 | Transfusion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116770813 | 11677081 | 1 | 20150101 | 20151009 | 0 |